Amanda Maxwell
European Regulatory Affairs Editor
European Regulatory Affairs Editor
UK
+35 year(s) experience
Amanda closely monitors the implementation of the Medical Device and IVD Regulations and the challenges that the sector is encountering is being in compliance in time. In so doing, she keeps in constant communication with a broad base of expert contacts around Europe. Moreover, as the UK heads for Brexit, she monitors the likely impact of political developments on the medtech sector.
Amanda also has experience in providing medtech regulatory strategy consultancy services, and is a frequently invited speaker and chair at EU meetings on medtech regulations and drug/device combination regulatory issues.
14 Aug 2019
Chirag Patel and Chintu Patel have returned to being co-CEOs of Amneal, just over a year after the firm completed its merger with Impax. Rob Stewart – who was president and CEO of Amneal – and executive chairman Paul Bisaro have resigned from the roles.
Generics Bulletin
By David Wallace 30 Jul 2019
As Sandoz reported its second-quarter financial results, the firm revealed details of a previously unannounced development program for biosimilar denosumab.
Topic Company analysis Biosimilars
Scrip: 世界の医療用医薬品＆製薬産...
16 May 2019
Pink Sheet: 世界の薬事規制と...
18 Apr 2019